The myths of parallel trade in medicines

Parallel trade in medicines brings direct savings for the destination country, as well as an important element of price competition to patented medicines. Attempts by manufacturers to stifle parallel trade are usually illegal, as well as counter-productive. Two current examples supply quota systems...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Consumer Policy Review 2004-01, Vol.14 (1), p.13
1. Verfasser:	Macarthur, Donald
Format:	Artikel
Sprache:	eng
Schlagworte:	Competition Cost control Free trade Health care policy Health insurance International law International trade Manufacturers Patients Pharmaceutical industry Prescription drugs Pricing policies Reimbursement Statistical data Wholesalers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Parallel trade in medicines brings direct savings for the destination country, as well as an important element of price competition to patented medicines. Attempts by manufacturers to stifle parallel trade are usually illegal, as well as counter-productive. Two current examples supply quota systems and free pricing with rebates - are described. This article develops themes that were raised in an earlier article 'Parallel trading of medicines: the case for a fair deal' (Consumer Policy Review 2001; 11:6-10). [PUBLICATION ABSTRACT]
ISSN:	0961-1134